AstraZeneca To Supply 500K Addl Doses Of Potential COVID-19 Antibody Treatment AZD7442 To US
AstraZeneca To Supply 500K Addl Doses Of Potential COVID-19 Antibody Treatment AZD7442 To US LONDON (dpa-AFX) - British drug major AstraZeneca Plc announced its agreement with the US Government to supply up to 500,000 additional doses of potential COVID-19 antibody treatment AZD7442. Following the announcement, AstraZeneca shares were gaining around 3 percent in the morning trade in London, and more than 1 percent in pre-market activity on Nasdaq. The company in October 2020 had agreed with the Department of Health and Human Services or HHS and the Department of Defense or DoD to supply for t...